Posts Tagged ‘needles’

California Adopts First US State Sharps EPR Program

Posted by GlobalPSC at 1:19 pm, October 12th, 2018Comments0

California Governor Jerry Brown signed SB 212 on 30 September, creating the first comprehensive, producer-funded take-back program for both home-generated sharps and unwanted medicines in the US. 

California now becomes the first US state to require extended producer responsibility (EPR) for sharps. France is the only country with national EPR for sharps.  

The California program requires producers or distributors to adopt and implement a stewardship program for covered drugs or sharps, as applicable, or to join a collective organisation to discharge those responsibilities. Key provisions require a proposed stewardship plan, initial stewardship program budget, annual budget, annual report, and other specified information. The state government, via CalRecycle, is to have regulations in place effective no later than 1 January 2021.

California joins New York as US states with mandated EPR laws for unwanted medicines (referred to as ‘covered drugs’ in AB 212) set to take effect. New York’s program became law in July 2018, with implementation to be effective mid-2019.

Takeback programs, either voluntary or regulated, for unwanted medicines exist in a range of states and countries globally.

 

Product Stewardship for Sharps and Unwanted Medicines – Background and Issues Paper Now Available

Posted by GlobalPSC at 12:06 pm, July 21st, 2017Comments0

The Global Product Stewardship Council (GlobalPSC) was asked by representatives of the US healthcare industry to assist in developing product stewardship for sharps in the US through independent research on product stewardship and extended producer responsibility (EPR) programs. The resulting Background and Issues Paper is now available on the GlobalPSC members-only Knowledge Base.

Under this initial work, the GlobalPSC conducted background research of existing global EPR programs for sharps and unwanted (or out-of-date) medicines and drafted the Background and Issues Paper to frame key issues and raise options for consideration by primary stakeholders (mainly sharps manufacturers and pharmaceutical companies with products using sharps).

Following discussions with primary stakeholders, their feedback was incorporated back into the Background and Issues Paper to provide one comprehensive report suitable for broader circulation and stakeholder engagement. The intention was to canvass possible approaches that could lead to program elements the industry could potentially support and to solicit broader stakeholder input. Funding for the Background and Issues Paper was provided by GlobalPSC Corporate Member Eli Lilly and Company.

GlobalPSC CEO Russ Martin presented an overview of the report and assisted stakeholder outreach during the Patient-Centered Safe Needle Disposal Forum 13 June 2017 in Washington, DC. The Forum was funded and led by Sharps Working Group members Abbvie, AstraZeneca, Becton Dickinson, Biogen, Dexcom, Eli Lilly and Company, Novo Nordisk, Perrigo, Roche and Sanofi.

 

Subscribe
Receive news and updates from us

GlobalPSC Facebook
 
Global Product Stewardship Council

PO Box 755, Turramurra, NSW 2074, Australia
Tel: +61 2 9489 8851
Fax: +61 2 9489 8553
Email: info@globalpsc.net